Connor, Clark & Lunn Investment Management »

Tg Therapeutics shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.9M 346k 17.08
2023-06-30 $8.1M 328k 24.84
2021-06-30 $730k 19k 38.80
2020-12-31 $1.3M 25k 52.01
2020-03-31 $395k 40k 9.85